CT
ALNY icon

Coastline Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Coastline Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,200
Closed -$230K – 244
2023
Q4 		$230K Hold
1,200
– – 0.03% 243
2023
Q3 		$213K Hold
1,200
– – 0.03% 245
2023
Q2 		$228K Hold
1,200
– – 0.03% 264
2023
Q1 		$240K Hold
1,200
– – 0.04% 265
2022
Q4 		$285K Hold
1,200
– – 0.04% 248
2022
Q3 		$240K Buy
+1,200
New +$229K 0.04% 282
2022
Q1 		– Sell
-1,200
Closed -$203K – 322
2021
Q4 		$203K Hold
1,200
– – 0.02% 327
2021
Q3 		$227K Hold
1,200
– – 0.03% 316
2021
Q2 		$203K Buy
+1,200
New +$176K 0.03% 320

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Coastline Trust's ALNY Position: Q1 2024 in Review

Coastline Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2024, closing a stake of 1,200 shares — an estimated $230K sold.

Coastline Trust first reported a position in ALNY in Q2 2021 and held it in 9 quarters. The position peaked at $285K in Q4 2022. 499 funds tracked by Wall St. Rank hold ALNY as of Q1 2024.

  • Coastline Trust reported no remaining Alnylam Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Coastline Trust sold 1,200 Alnylam Pharmaceuticals shares in Q1 2024, an estimated $230K.
  • Coastline Trust first reported a position in Alnylam Pharmaceuticals in Q2 2021 and held it in 9 quarters.
  • Coastline Trust's Alnylam Pharmaceuticals position peaked at $285K in Q4 2022.
  • 499 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2024.

Based on Coastline Trust's 13F filing for Q1 2024, filed 26 Apr 2024.